If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the U.S. and internationally.

The company’s stock traded at approximately $31.75 per share 10 years ago. If you had invested $10,000, you could have bought roughly 315 shares. Currently, shares trade at $23.87, meaning your investment’s value could have declined to $7,518 from stock price depreciation. However, Pfizer also paid dividends during these 10 years.

Don’t Miss:

Pfizer’s dividend yield is currently 7.21%. Over the last 10 years, it has paid about $14.84 in dividends per share, which means you could have made $4,674 from dividends alone.

Summing up $7,518 and $4,674, we end up with the final value of your investment, which is $12,192. This is how much you could have made if you had invested $10,000 in Pfizer stock 10 years ago. This means a total return of 21.92%. However, this figure is significantly less than the S&P 500 total return for the same period, which was 220.74%.

Pfizer has a consensus rating of “Neutral” and a price target of $33.32 based on the ratings of 24 analysts. The price target implies a nearly 40% potential upside from the current stock price.

Trending: Donald Trump Just Announced a $500 Billion AI Infrastructure Deal — Here’s How You Can Invest in the Entertainment Market’s Next Big Disruptor for Just $998

On April 29, the company announced its Q1 2025 earnings, posting adjusted EPS of $0.92, beating the consensus estimate of $0.67, as reported by Benzinga. The company’s sales fell 8% year-over-year to $13.71 billion, below the consensus of $13.95 billion.

Pfizer reaffirmed its full-year 2025 revenue guidance of $61 billion to $64 billion, compared to the consensus of $62.93 billion. The company anticipates adjusted EPS to be in the range of $2.80 to $3.00, compared to the consensus estimate of $2.96.

Given the expected upside potential of 40%, growth-focused investors may find Pfizer stock attractive. Furthermore, they can benefit from the company’s solid dividend yield of 7.21% and consistent hikes. Pfizer has raised its dividend consecutively for the last 15 years.